Orbimed Advisors - SYNERGY PHARMACEUTICALS DEL ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2017$39,502,000
-58.0%
13,621,443
-35.6%
0.38%
-61.7%
Q2 2017$94,132,000
-4.5%
21,153,3430.0%0.99%
-11.6%
Q1 2017$98,575,000
-11.3%
21,153,343
+16.0%
1.12%
-21.1%
Q4 2016$111,090,000
+237.3%
18,241,398
+205.2%
1.42%
+277.6%
Q3 2016$32,931,000
+45.0%
5,976,6480.0%0.38%
+58.2%
Q2 2016$22,711,000
+261.4%
5,976,648
+162.5%
0.24%
+259.1%
Q1 2016$6,284,000
-51.3%
2,276,6480.0%0.07%
-43.6%
Q4 2015$12,909,000
+7.0%
2,276,6480.0%0.12%
-4.1%
Q3 2015$12,066,000
-56.9%
2,276,648
-32.5%
0.12%
-40.5%
Q2 2015$27,981,000
+94.0%
3,371,148
+8.0%
0.20%
+66.7%
Q1 2015$14,420,0003,121,1480.12%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2023
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,767,858$3,235,0004.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,505,809$2,726,0001.06%
Nantahala Capital Management 11,578,568$21,189,0000.96%
Hikari Power Ltd 2,000,000$3,660,0000.43%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,376,708$2,519,0000.20%
KNOTT DAVID M 225,400$412,0000.17%
Truepoint, Inc. 37$20,000,0000.16%
Clear Harbor Asset Management, LLC 283,560$519,0000.10%
Malaga Cove Capital, LLC 97,266$178,0000.10%
Lehman Financial Resources, Inc. 70,800$129,0000.07%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders